Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Remimazolam for Cataract Surgery | Cataract Surgery Anesthesia | Not yet recruiting | Phase 4 | 2026-07-15 | NCT07325227 | |
| Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bacterial pneumonia, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Phase 2 | 2026-01-28 | NCT05776004 |